Secondly, by activating tumor associated macrophages, myeloid-derived suppressive cells, Cd4+Foxp3+Treg cells or Th17 cells, inflammation could impair the immune response within tumors, promoting immune deficiency and cancer progression (51). This evidence concerns the gene CD4 and neoplasm.